Table 2 Distribution of metastatic sites in patients with stage IV lung carcinoids
Site | Sites represented in pathological specimens | Sites Involved based on radiological data | ||
|---|---|---|---|---|
N | % of metastatic samples (n = 93) | N | % of patients (n = 66) | |
Liver | 31 | 33 | 49 | 74 |
Regional Lymph Nodes | 13 | 14 | 42 | 64 |
Bone | 9 | 10 | 37 | 56 |
Brain | 6 | 6 | 21 | 32 |
Extra-thoracic Lymph Nodes | 2 | 2 | 11 | 17 |
Adrenal | 1 | 1 | 11 | 17 |
Peritoneum | 0 | 0 | 8 | 12 |
Skin/Subcutaneous | 10 | 11 | 8 | 12 |
Contralateral Lung | 0 | 0 | 7 | 11 |
Pleura | 3 | 3 | 7 | 11 |
Breast | 2 | 2 | 5 | 8 |
Eye | 0 | 0 | 5 | 8 |
Pancreas | 0 | 0 | 4 | 6 |
Ovary | 4 | 4 | 4 | 6 |
Other | 12 | 13 | 23a | <5% for each site |